LPA and diabetes mellitus: Previous studies have investigated the contribution of Lp(a) as risk factor in patients and without diabetes, but this evidence is limited to the general population or to patients with chronic coronary syndrome (CCS).[10–13] ACS patients have a higher risk profile, with an estimated MACCE incidence at 1 year of about 20%.